Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The Mexico medical cannabis market was valued at USD 449.55 Million in 2025. It is poised to grow at a CAGR of 21.50% during the forecast period of 2026-2035, and reach USD 3151.67 Million by 2035. The growth is supported by the rising burden of chronic pain and cancer alongside progressive regulatory advancements led by COFEPRIS that continue to widen patient access to cannabis-based therapeutics across hospitals, pharmacies, and licensed distributors.
According to GrowerIQ, Mexico's medical cannabis market continued to operate within a complex regulatory gray zone in April 2026 as COFEPRIS issued zero commercial recreational distribution licenses. Activity remains limited to medical and research uses, with applicants relying on judicial amparo procedures, reinforcing slow but accelerating commercial traction and durable long-term growth potential across the Mexico medical cannabis market.
According to MMJ Daily, COFEPRIS granted official import licenses in early 2026 to HGI Industrial Technologies and Santa Rosa Green Seeds, authorizing importation, registration, and commercialization of CBD, CBG, and other cannabinoid products containing under 1 percent THC. The approvals signal incremental regulatory progress and reinforce gradual commercial expansion across the Mexico medical cannabis market.
Compound Annual Growth Rate
21.5%
Value in USD Million
2026-2035
Medical cannabis refers to therapeutic products derived from the Cannabis sativa plant, including buds, oils, and tinctures, used to manage chronic pain, mental disorders, cancer-related symptoms, epilepsy, and neurological conditions. The principal active compounds are tetrahydrocannabinol (THC) and cannabidiol (CBD). The market was valued at USD 449.55 Million in 2025 and is poised to grow at a CAGR of 21.50%. Expanding investments in pharmaceutical cannabis products, improving healthcare access, and ongoing government initiatives supporting medical cannabis legalization are further contributing to market development.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rising Burden of Chronic Pain in Mexico is Set to Boost Market Expansion
The growing prevalence of chronic pain conditions in Mexico is increasingly driving demand for medical cannabis products as patients seek alternative approaches for long-term symptom management. As per Gutiérrez-Mendoza et al., 2026, a multicentre study covering 6,895 adult patients across private orthopaedic clinics in 30 of Mexico's 32 states reported a 54% prevalence of nociceptive pain and 5.2% prevalence of neuropathic pain phenotypes between January 2023 and April 2024. The substantial burden of chronic pain, particularly mixed and neuropathic pain conditions, is expected to support the growing adoption of cannabis-based products such as CBD oils, tinctures, and full-spectrum extracts across specialty clinics and licensed distribution channels in Mexico.
The market is witnessing several trends including regulatory modernization, import compliance tightening, and structured medical cannabis frameworks.
Strengthening Regulatory Modernization and Import Compliance Framework to Enhance Market Growth
The market is witnessing a regulatory transformation driven by stricter import compliance and digital modernization of approval systems. This trend is strengthening COFEPRIS oversight while streamlining medical-use CBD import pathways through faster digital authorizations and improved documentation standards. For instance, May 2026 regulatory analysis highlighted that COFEPRIS reforms introduced in June 2025, along with the 2026 customs reform, are increasing audit requirements, duties, and classification controls for CBD imports. This evolving regulatory structure is expected to enhance transparency, improve supply chain governance, and support sustained market growth.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Product
Market Breakup by Application
Market Breakup by Distribution Channel
Market Breakup by End User
Oils and Tinctures Segment is Likely to Lead the Market by Product
The market is segmented by product into flowers, oils, and tinctures. Among these, oils and tinctures are expected to lead due to their higher medical acceptance, precise dosing advantages, and suitability for regulated therapeutic applications. These formulations are widely preferred in clinical practice as they enable consistent cannabinoid delivery, improved patient compliance, and better treatment control for chronic conditions. Their standardized composition aligns well with pharmaceutical-grade requirements, making them more suitable for physician-guided use compared to raw flower-based products. Overall, this segment is expected to drive structured adoption and support the continued formalization of medical cannabis-based therapies.
The key features of the market report comprise strategic initiatives by the leading players. The major companies in the market are as follows:
Aurora Cannabis, headquartered in Edmonton, Canada, supplies medical cannabis products including dried flower, oils, and softgels to international markets. The company maintains EU-GMP certified production facilities and supports medical cannabis distribution across various regions, serving chronic pain and oncology patient populations.
Canopy Growth, headquartered in Smiths Falls, Ontario, Canada, supplies medical cannabis through its Spectrum Therapeutics brand, including dried flower, oils, and softgels for international medical markets. The company maintains EU-GMP certified production capacity and supports patient access programmes.
Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company operating across medical cannabis, adult-use cannabis, and wellness segments. In the medical cannabis market, Tilray offers pharmaceutical-grade products through its Tilray Medical and Aphria Medical portfolios. The company plays a key role in international medical cannabis supply chains, supporting regulated distribution and expanding access to standardized cannabis-based therapies across market.
Clever Leaves Holdings, Inc. is a pharmaceutical-grade cannabis company specializing in the cultivation, extraction, and distribution of medical cannabis products. Its portfolio includes standardized cannabis extracts and dried flower products designed for medical applications. The company is actively involved in the market through regulatory-compliant exports, leveraging GMP-certified facilities and a strong international supply chain to support healthcare providers and patients in regulated markets worldwide.
Other key players in the market are Khiron Life Sciences Corp., CV Sciences, Inc., and many more.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Application |
|
| Breakup by Distribution Channel |
|
| Breakup by End User |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.